Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00952692
Recruitment Status : Completed
First Posted : August 6, 2009
Last Update Posted : November 20, 2012
Information provided by (Responsible Party):
Michael Morse, MD, Duke University